Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial
https://www.sciencedirect.com/science/article/pii/S1341321X21002397
Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0247163
Favorable outcome on viral load and culture viability using Ivermectin in early treatment of non-hospitalized patients with mild COVID-19 – A double-blind, randomized placebo- controlled trial.
i: https://doi.org/10.1101/2021.05.31.21258081
Vaccinating people who have had covid-19: why doesn’t natural
immunity count in the US?
Cite this as: BMJ 2021;374:n2101
http://dx.doi.org/10.1136/bmj.n2101